Push it! But Which Vasopressor? (1 Class A CE with 1 Pharm)

Wise researchers have said anesthesia providers have been in a “phenylephrine pandemic” for the past several years. Yes, we need to treat hemodynamic instability at times by pushing vasopressors, but are we choosing the right one? Recently published studies reported an association between phenylephrine and postoperative acute kidney injury and delirium. CRNAs are well-educated on the determinants of cardiac output, but evidence suggests these concepts are not guiding intraoperative hemodynamic management. Blood pressure does not equal flow to the organs, and the entire picture of perfusion should be addressed. One method uses advanced hemodynamic monitoring, which provides additional information, allowing the anesthesia clinician to provide the individualized treatment needed to correct hemodynamic instability. We want to raise awareness of recent evidence demonstrating that choosing the incorrect treatment for intraoperative hemodynamic management may cause iatrogenic harm. We need education on the various effects and patient outcomes associated with phenylephrine, norepinephrine, and ephedrine. Along with pharmacology continuing education credit, we aim for you to leave this session with more confidence knowing which vasopressor to push!

Class A credit can only be earned for participation in synchronous learning via live in-person or live webinar sessions. In-person attendees can only receive Class A credit for the sessions they attend live.

Due to CE guidelines, sessions which are recorded will not be available for viewing immediately following Congress.